Whether you are watching television, scrolling through Instagram, or catching up with an old friend, the topic of weight loss ...

Altimmune, Inc. (NASDAQ:ALT – Get Free Report) was the recipient of unusually large options trading activity on Friday. Stock ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A recent study suggests that GLP-1 receptor agonists (GLP-1RAs) may lower the risk of hematologic cancers, including leukemia ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

Shares of Altimmune ( NASDAQ: ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors ...

Weight loss drugs like Ozempic deliver more health benefits than expected.

An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a ...

The rise of GLP-1s (glucagon-like peptides) has revolutionized obesity management. These medications help people shed pounds ...

The following is a summary of “Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a ...

Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...